These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 818390)

  • 41. [Ambulatory care of Parkinson-disease patients in a general hospital].
    Gimenez-Roldan S; Mateo D; Villanueva J
    Rev Clin Esp; 1977 Nov; 147(3):297-302. PubMed ID: 605241
    [No Abstract]   [Full Text] [Related]  

  • 42. Modification of Parkinson's disease by long-term levodopa treatment.
    Markham CH; Diamond SG
    Arch Neurol; 1986 Apr; 43(4):405-7. PubMed ID: 3082316
    [No Abstract]   [Full Text] [Related]  

  • 43. Long-term levodopa in Parkinson's disease.
    Yahr MD
    Lancet; 1977 Mar; 1(8013):706-7. PubMed ID: 66509
    [No Abstract]   [Full Text] [Related]  

  • 44. [Today's treatment of Parkinsonism].
    Ferel D
    Schweiz Rundsch Med Prax; 1978 Jul; 67(27):987-9. PubMed ID: 97649
    [No Abstract]   [Full Text] [Related]  

  • 45. Levodopa: long-term impact on Parkinson's disease.
    Mann DM; Yates PO
    Br Med J (Clin Res Ed); 1981 Mar; 282(6268):985-6. PubMed ID: 6781685
    [No Abstract]   [Full Text] [Related]  

  • 46. Long-term influence of levodopa on bone mass and growth hormone in postmenopausal women with Parkinson's disease.
    Rico H; Vazquez A; Cabranes JA; Cantizano L; Hernandez ER; Krisnik I; Varela de Seijas E
    Clin Neuropharmacol; 1987; 10(1):87-91. PubMed ID: 3815389
    [No Abstract]   [Full Text] [Related]  

  • 47. Fava beans and Parkinson's disease: useful 'natural supplement' or useless risk?
    Raguthu L; Varanese S; Flancbaum L; Tayler E; Di Rocco A
    Eur J Neurol; 2009 Oct; 16(10):e171. PubMed ID: 19678834
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinical and radiographic features of scoliosis in Parkinson's disease.
    Grimes JD; Hassan MN; Trent G; Halle D; Armstrong GW
    Adv Neurol; 1987; 45():353-5. PubMed ID: 3825710
    [No Abstract]   [Full Text] [Related]  

  • 49. Long term clinical care of parkinson's disease. A symposium. Tokyo, April 21, 1990.
    Eur Neurol; 1991; 31 Suppl 1():1-59. PubMed ID: 1855520
    [No Abstract]   [Full Text] [Related]  

  • 50. Parkinson's disease and long-term levodopa therapy.
    Bergmann KJ; Mendoza MR; Yahr MD
    Adv Neurol; 1987; 45():463-7. PubMed ID: 3103389
    [No Abstract]   [Full Text] [Related]  

  • 51. Intermittent levodopa therapy in parkinsonism.
    Koller WC
    Adv Neurol; 1983; 37():45-50. PubMed ID: 6407286
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Parkinson's disease in the elderly: a long-term efficacy study of levodopa/benserazide combination therapy.
    Mondal BK; Mondal KN
    Pharmatherapeutica; 1986; 4(9):571-6. PubMed ID: 3094036
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Results of prolonged treatment of Parkinson's disease with the L-dopa-benserazide combination].
    Casacchia M; Barba C; Ruggieri S; Zamponi A; Agnoli A
    Riv Neurol; 1974; 44(5):303-30. PubMed ID: 4217465
    [No Abstract]   [Full Text] [Related]  

  • 54. Results of present-day therapy of Parkinson's disease.
    Stellar S; Bhandari Y
    J Med Soc N J; 1976 Apr; 73(4):313-7. PubMed ID: 818390
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.